When someone is affected by a stroke, the standard treatment to restore blood flow to the brain can both save their life and ...

Gaps in the U.S. stroke transfer system are drastically reducing survivors' chances of receiving critical treatment and ...

Currently in phase 2 trials, BB-031 is the first new mechanistic approach to ischemic stroke treatment in nearly 30 years.

Delays in transferring patients with stroke for advanced treatment are linked to worse disability, fewer lifesaving procedures, and more complications, a large US study shows.

Gaps in the nation's stroke transfer system are drastically reducing survivors' chances of receiving critical treatment and ...

In patients with acute ischemic stroke and elevated high-sensitivity cardiac troponin (hs-cTn), dynamic changes in hs-cTn are not helpful in identifying myocardial infarction (MI) or distinguishing MI ...

TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...

Please provide your email address to receive an email when new articles are posted on . TNKase is the first stroke treatment approved by the FDA in almost 30 years, the manufacturer said. It is ...

For acute ischemic stroke within 48 hours of onset, the novel sublingual combination of edaravone (Radicava) with dexborneol appeared to dramatically improve functional outcomes in the phase III TASTE ...

Gaps in the U.S. stroke transfer system are drastically reducing survivors' chances of receiving critical treatment and ...

The Indian Council of Medical Research (ICMR) on Wednesday handed over two Mobile Stroke Units (MSUs) to the Government of ...